CDC20, TOP2A and NEK2 Expression in Esophageal Squamous Cell Carcinoma and Its Clinical Significance

Abstract

Objective: to study the expression and clinical significance CDC20,TOP2A, NEK2 esophageal squamous cell carcinoma. Methods: Toselect 70 patients with esophageal squamous cell carcinoma, Between August 2018 - August 2020, All intraoperative pathological specimens,A group -35 cases), Cancer tissue, B group, adjacent tissues), two groups of CDC20, TOP2A, NEK 2 expression were detected and analyzed by immunohistochemistry and semi-quantitative reverse transcription polymerase chain reaction -RT-PcR) assay.Results: the values of CDC20,TOP2A, NEK2 expression level in A group were significantly higher thanthose in B group -P<0.05). The expression level CDC20, TOP2A, NEK2esophageal squamous cell carcinoma was positively correlated with TNMstage and lymphatic metastasis, and negatively correlated with tumordifferentiation. Conclusion: CDC20, TOP2A, NEK2 high expression leveldirectly affects the metastasis, recurrence and prognosis of esophagealsquamous cell carcinoma. The combination of three indexes can accuratelyevaluate the pathological status of patients with esophageal squamous cellcarcinoma and help to judge the prognosis of patients accurately